- Home
- WFG vs LNTH Comparison
WFG vs LNTH Comparison
Compare WFG & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFG
- LNTH
- Stock Information
- Founded
- WFG 1955
- LNTH 1956
- Country
- WFG Canada
- LNTH United States
- Employees
- WFG N/A
- LNTH N/A
- Industry
- WFG
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- WFG
- LNTH Health Care
- Exchange
- WFG Nasdaq
- LNTH Nasdaq
- Market Cap
- WFG 7.5B
- LNTH 7.5B
- IPO Year
- WFG N/A
- LNTH 2015
- Fundamental
- Price
- WFG $75.31
- LNTH $79.67
- Analyst Decision
- WFG Buy
- LNTH Strong Buy
- Analyst Count
- WFG 3
- LNTH 5
- Target Price
- WFG $105.00
- LNTH $133.80
- AVG Volume (30 Days)
- WFG 166.0K
- LNTH 1.2M
- Earning Date
- WFG 04-22-2025
- LNTH 05-07-2025
- Dividend Yield
- WFG 1.67%
- LNTH N/A
- EPS Growth
- WFG N/A
- LNTH N/A
- EPS
- WFG N/A
- LNTH 3.53
- Revenue
- WFG $6,006,000,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- WFG $4.88
- LNTH $5.81
- Revenue Next Year
- WFG $7.24
- LNTH $12.26
- P/E Ratio
- WFG $2,957.78
- LNTH $22.52
- Revenue Growth
- WFG N/A
- LNTH 12.53
- 52 Week Low
- WFG $69.48
- LNTH $74.34
- 52 Week High
- WFG $102.40
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- WFG 55.51
- LNTH 28.34
- Support Level
- WFG $73.75
- LNTH $78.92
- Resistance Level
- WFG $75.77
- LNTH $108.91
- Average True Range (ATR)
- WFG 1.82
- LNTH 3.92
- MACD
- WFG 0.34
- LNTH -3.09
- Stochastic Oscillator
- WFG 66.76
- LNTH 3.00
About WFG West Fraser Timber Co. Ltd Common stock
West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is now one of the largest oriented strand board, or OSB, producers in the world.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.